{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:41:31Z","timestamp":1792269691065,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Early detection of X-linked agammaglobulinemia (XLA) and other profound B cell lymphopenias (BCL) in newborns is crucial for timely intervention and improved clinical outcomes. The kappa light chain rearrangement excision circles (KREC) assay has emerged as an effective specific and sensitive tool for newborn screening (NBS) of XLA and other BCL. Large-scale studies have demonstrated that KREC-based NBS identifies affected infants before symptom onset, enabling prompt initiation of immunoglobulin replacement therapy (IGRT) and prophylactic antibiotics, thereby preventing recurrent infections, chronic organ damage, and reducing healthcare burden. Here, we evaluate the possible cost-benefit of NBS for XLA and other BCL. Economic evaluation shows that adding KREC screening to existing NBS programs is likely to be cost-effective and fulfills established criteria for NBS inclusion, supporting its adoption in universal NBS protocols.<\/jats:p>","DOI":"10.1007\/s12026-026-09842-7","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:59:19Z","timestamp":1789451959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The cost-benefit of newborn screening for X-linked agammaglobulinemia and related B-cell lymphopenia"],"prefix":"10.1007","volume":"74","author":[{"given":"Eyal","family":"Grunebaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Tenembaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Modell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raz","family":"Somech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"9842_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1542\/peds.32.3.338","volume":"32","author":"R Guthrie","year":"1963","unstructured":"Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338\u201343.","journal-title":"Pediatrics"},{"issue":"1","key":"9842_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijns7010005","volume":"7","author":"HL Levy","year":"2021","unstructured":"Levy HL. Robert guthrie and the trials and tribulations of newborn screening. Int J Neonatal Screen. 2021;7(1):5.","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"9842_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2471\/blt.07.050112","volume":"86","author":"A Andermann","year":"2008","unstructured":"Andermann A, Blancquaert I, B eauchamp S, D\u00e9ry V. Bull World Health Organ. 2008;86(4):317\u20139. https:\/\/doi.org\/10.2471\/blt.07.050112","journal-title":"Bull World Health Organ"},{"issue":"5","key":"9842_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jaip.2026.02.032","volume":"14","author":"J Aluri","year":"2026","unstructured":"Aluri J, Gaviglio A, Kistler I, et al. Assessment of TREC-based NBS SCID reporting practices for harmonization of results and interpretation: A global survey. J Allergy Clin Immunol Pract. 2026;14(5):1153\u201364. https:\/\/doi.org\/10.1016\/j.jaip.2026.02.032","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10396","key":"9842_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0140-6736(23)00731-6","volume":"402","author":"MS Thakar","year":"2023","unstructured":"Thakar MS, Logan BR, Puck JM, et al. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet. 2023;402(10396):129\u201340.","journal-title":"Lancet"},{"issue":"6","key":"9842_CR6","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.jaci.2025.01.029","volume":"155","author":"C Anchoo","year":"2025","unstructured":"Anchoo C, Lev A, Simon AJ, et al. Outcome of hematopoietic stem cell transplantation for severe combined immunodeficiency and impact of newborn screening on overall survival: A single referral center study. J Allergy Clin Immunol. 2025;155(6):1800\u201312.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9842_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13223-022-00662-6","volume":"18","author":"J Quinn","year":"2022","unstructured":"Quinn J, Modell V, Orange JS, Modell F. Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network. Allergy Asthma Clin Immunol. 2022;18(1):19.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"9842_CR8","doi-asserted-by":"publisher","first-page":"e20250020","DOI":"10.70962\/jhi.20250020","volume":"1","author":"H Kanegane","year":"2025","unstructured":"Kanegane H, Kay Tanita M, Nishimura M, et al. Revisiting X-linked agammaglobulinemia. J Hum Immun. 2025;1(1):e20250020.","journal-title":"J Hum Immun"},{"key":"9842_CR9","doi-asserted-by":"publisher","first-page":"1645337","DOI":"10.3389\/fimmu.2025.1645337","volume":"6","author":"P Wu","year":"2025","unstructured":"Wu P, You W, Liu W, et al. Fatal X-linked agammaglobulinemia complicated by septic shock: a case report and comprehensive review of novel BTK mutations. Front Immunol. 2025;6:1645337.","journal-title":"Front Immunol"},{"key":"9842_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.coi.2021.05.006","volume":"72","author":"F Gothe","year":"2021","unstructured":"Gothe F, Howarth S, Duncan CJ, Hambleton S. Monogenic susceptibility to live viral vaccines. Curr Opin Immunol. 2021;72:167\u201375.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"9842_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jaci.2020.03.001","volume":"146","author":"V Lougaris","year":"2020","unstructured":"Lougaris V, Soresina A, Baronio M, et al. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality. J Allergy Clin Immunol. 2020;146(2):429\u201337.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9842_CR12","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.waojou.2019.100018","volume":"12","author":"ZA El-Sayed","year":"2019","unstructured":"El-Sayed ZA, Abramova I, Aldave JC, et al. X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organ J. 2019;12(3):100018.","journal-title":"World Allergy Organ J"},{"issue":"1","key":"9842_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12883-019-1536-7","volume":"19","author":"YN Zhang","year":"2019","unstructured":"Zhang YN, Gao YY, Yang SD, et al. Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis. BMC Neurol. 2019;19(1):320.","journal-title":"BMC Neurol"},{"issue":"4","key":"9842_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10875-022-01222-8","volume":"42","author":"K Altman","year":"2022","unstructured":"Altman K, Zhou C, Hernandez-Trujillo V, et al. Health-related quality of life in 91 patients with X-linked agammaglobulinemia. J Clin Immunol. 2022;42(4):811\u20138.","journal-title":"J Clin Immunol"},{"issue":"1","key":"9842_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2014.09.003","volume":"155","author":"S Borte","year":"2014","unstructured":"Borte S, Fasth A, von D\u00f6beln U, et al. Newborn screening for severe T and B cell lymphopenia identifies a fraction of patients with Wiskott-Aldrich syndrome. Clin Immunol. 2014;155(1):74\u20138.","journal-title":"Clin Immunol"},{"issue":"4","key":"9842_CR16","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.3389\/fimmu.2018.02756","volume":"9","author":"CJ Collins","year":"2018","unstructured":"Collins CJ, Chang IJ, Jung S, et al. Rapid multiplexed proteomic screening for primary immunodeficiency disorders from dried blood spots. Front Immunol. 2018;9(4):2756.","journal-title":"Front Immunol"},{"issue":"12","key":"9842_CR17","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.ajhg.2024.10.021","volume":"111","author":"SF Kingsmore","year":"2024","unstructured":"Kingsmore SF, Wright M, Smith LD, et al. Prequalification of genome-based newborn screening for severe childhood genetic diseases through federated training based on purifying hyperselection. Am J Hum Genet. 2024;111(12):2618\u201342.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"9842_CR18","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1182\/blood-2011-08-371021","volume":"119","author":"S Borte","year":"2012","unstructured":"Borte S, von D\u00f6beln U, Fasth A, et al. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood. 2012;119(11):2552\u20135.","journal-title":"Blood"},{"issue":"1","key":"9842_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4081\/jphr.2013.e3","volume":"2","author":"M Chiarini","year":"2013","unstructured":"Chiarini M, Zanotti C, Serana F, et al. T-cell receptor and K-deleting recombination excision circles in newborn screening of T- and B-cell defects: Review of the literature and future challenges. J Public Health Res. 2013;2(1):9\u201316.","journal-title":"J Public Health Res"},{"issue":"5","key":"9842_CR20","doi-asserted-by":"publisher","first-page":"e70100","DOI":"10.1111\/pai.70100","volume":"36","author":"M Bloomfield","year":"2025","unstructured":"Bloomfield M, Hlav\u00e1\u010dkov\u00e1 E, Schneiderov\u00e1 H, et al. Beyond TREC: Pivotal role of tandem TREC\/KREC assay in Czech SCID NBS pilot programme. Pediatr Allergy Immunol. 2025;36(5):e70100.","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"9842_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10875-024-01691-z","volume":"5","author":"AV Marakhonov","year":"2024","unstructured":"Marakhonov AV, Efimova IY, Mukhina AA, et al. Newborn screening for severe T and B cell lymphopenia using TREC\/KREC detection: A large-scale pilot study of 202,908 newborns. J Clin Immunol. 2024;5(4):93.","journal-title":"J Clin Immunol"},{"key":"9842_CR22","doi-asserted-by":"publisher","first-page":"1742811","DOI":"10.3389\/fimmu.2026.1742811","volume":"17","author":"A Marakhonov","year":"2026","unstructured":"Marakhonov A, Mukhina A, Efimova I, et al. First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia. Front Immunol. 2026;17:1742811.","journal-title":"Front Immunol"},{"key":"9842_CR23","doi-asserted-by":"publisher","first-page":"1709657","DOI":"10.3389\/fimmu.2025.1709657","volume":"16","author":"O Boyarchuk","year":"2025","unstructured":"Boyarchuk O, Makukh H, Volokha A, et al. Newborn screening for SCID and severe T- and B-cell lymphopenia in Ukraine: the first analysis of the results, 2022\u20132025. Front Immunol. 2025;16:1709657.","journal-title":"Front Immunol"},{"issue":"1","key":"9842_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jaip.2025.10.031","volume":"4","author":"M Soomann","year":"2026","unstructured":"Soomann M, Prader S, Sluka S, et al. Five years of combined newborn screening quantifying TREC and KREC in Switzerland. J Allergy Clin Immunol Pract. 2026;4(1):243\u201352.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"9842_CR25","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s12519-024-00846-7","volume":"20","author":"C Chen","year":"2024","unstructured":"Chen C, Zhang C, Wu DW, et al. Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience. World J Pediatr. 2024;20(12):1270\u201382.","journal-title":"World J Pediatr"},{"issue":"9","key":"9842_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3345\/cep.2025.00052","volume":"68","author":"R Rana","year":"2025","unstructured":"Rana R, Afroz Keramat S, Ahmed M. Cost-effectiveness of newborn screening for severe combined immunodeficiency: a systematic review. Clin Exp Pediatr. 2025;68(9):628\u201340.","journal-title":"Clin Exp Pediatr"},{"issue":"1","key":"9842_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12026-014-8485-4","volume":"60","author":"V Modell","year":"2014","unstructured":"Modell V, Knaus M, Modell F. An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia. Immunol Res. 2014;60(1):145\u201352.","journal-title":"Immunol Res"},{"issue":"4","key":"9842_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","volume":"85","author":"JA Winkelstein","year":"2006","unstructured":"Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Med (Baltim). 2006;85(4):193\u2013202.","journal-title":"Med (Baltim)"},{"issue":"4","key":"9842_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10875-008-9270-8","volume":"29","author":"A Soresina","year":"2009","unstructured":"Soresina A, Nacinovich R, Bomba M, et al. The quality of life of children and adolescents with X-linked agammaglobulinemia. J Clin Immunol. 2009;29(4):501\u20137.","journal-title":"J Clin Immunol"},{"issue":"1","key":"9842_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10875-025-01904-z","volume":"45","author":"M Blom","year":"2025","unstructured":"Blom M, Duintjer AJ, Jamee M, et al. Self-reported clinical outcomes and quality of life in agammaglobulinemia: The importance of an early diagnosis. J Clin Immunol. 2025;45(1):125. Erratum in: J Clin Immunol. 2025; 45(1):142.","journal-title":"J Clin Immunol"},{"issue":"4","key":"9842_CR31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10875-022-01237-1","volume":"42","author":"D O\u2019Toole","year":"2022","unstructured":"O\u2019Toole D, Groth D, Wright H, et al. X-linked agammaglobulinemia: Infection frequency and infection-related mortality in the USIDNET registry. J Clin Immunol. 2022;42(4):827\u201336.","journal-title":"J Clin Immunol"},{"issue":"2","key":"9842_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1440-1843.2009.01679.x","volume":"15","author":"A Aghamohammadi","year":"2010","unstructured":"Aghamohammadi A, Allahverdi A, Abolhassani H, et al. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology. 2010;15(2):289\u201395.","journal-title":"Respirology"},{"issue":"5","key":"9842_CR33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2500\/aap.2024.45.240060","volume":"45","author":"JC Hsueh","year":"2024","unstructured":"Hsueh JC, Van Hersh AT, Zhao W. Immunodeficiency: Burden of illness. Allergy Asthma Proc. 2024;45(5):294\u20138.","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"9842_CR34","doi-asserted-by":"publisher","first-page":"e0175867","DOI":"10.1371\/journal.pone.0175867","volume":"12","author":"E Guan\u00ed-Guerra","year":"2017","unstructured":"Guan\u00ed-Guerra E, Jim\u00e9nez-Romero AI, Garc\u00eda-Ram\u00edrez UN, et al. Disease burden for patients with primary immunodeficiency diseases identified at reference hospitals in Guanajuato, Mexico. PLoS ONE. 2017;12(4):e0175867.","journal-title":"PLoS ONE"},{"issue":"2","key":"9842_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapediatrics.2021.4583","volume":"176","author":"D Sun","year":"2022","unstructured":"Sun D, Heimall JR, Greenhawt MJ, et al. Cost utility of lifelong immunoglobulin replacement therapy vs hematopoietic stem cell transplant to treat agammaglobulinemia. JAMA Pediatr. 2022;176(2):176\u201384.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"9842_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13223-022-00735-6","volume":"18","author":"B Ritchie","year":"2022","unstructured":"Ritchie B, Martins KJB, Tran DT, et al. Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study. Allergy Asthma Clin Immunol. 2022;18(1):99.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"22","key":"9842_CR37","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1001\/jama.2009.1806","volume":"302","author":"JM Routes","year":"2009","unstructured":"Routes JM, Grossman WJ, Verbsky J, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA. 2009;302(22):2465\u201370.","journal-title":"JAMA"},{"issue":"3","key":"9842_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ymgme.2011.07.007","volume":"104","author":"K Chan","year":"2011","unstructured":"Chan K, Davis J, Pai SY, et al. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab. 2011;104(3):383\u20139.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"9842_CR39","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s10875-023-01502-x","volume":"43","author":"V Hernandez-Trujillo","year":"2023","unstructured":"Hernandez-Trujillo V, Zhou C, Scalchunes C, et al. A registry study of 240 patients with x-linked agammaglobulinemia living in the USA. J Clin Immunol. 2023;43(6):1468\u201377.","journal-title":"J Clin Immunol"},{"issue":"5","key":"9842_CR40","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.4049\/jimmunol.134.5.3070","volume":"134","author":"ME Conley","year":"1985","unstructured":"Conley ME. B cells in patients with X-linked agammaglobulinemia. J Immunol. 1985;134(5):3070\u20134.","journal-title":"J Immunol"},{"issue":"1","key":"9842_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaci.2021.05.028","volume":"149","author":"CJ Nunes-Santos","year":"2022","unstructured":"Nunes-Santos CJ, Koh C, et al. Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication. J Allergy Clin Immunol. 2022;149(1):400\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9842_CR42","doi-asserted-by":"publisher","first-page":"101555","DOI":"10.1016\/j.omtm.2025.101555","volume":"33","author":"CR Luthers","year":"2025","unstructured":"Luthers CR, Mittelhauser A, Colamartino A et al. Hematopoietic stem cell gene therapy for the treatment of X-linked agammaglobulinemia. Mol Ther Methods Clin Dev. 2025;33(3):101555.","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09842-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:59:20Z","timestamp":1789451960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09842-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9842"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09842-7","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"111"}}